Pagonabarraga J - Search Results

1

Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa.

Kulisevsky J, Bejr-Kasem H, Martinez-Horta S, Horta-Barba A, Pascual-Sedano B, Campolongo A, Marín-Lahoz J, Aracil-Bolaños I, Pérez-Pérez J, Izquierdo-Barrionuevo C, de Fàbregues O, Puente V, Crespo-Cuevas A, Calopa M, Pagonabarraga J. Kulisevsky J, et al. Among authors: pagonabarraga j. J Neurol. 2020 Nov;267(11):3400-3410. doi: 10.1007/s00415-020-10018-y. Epub 2020 Jun 30. J Neurol. 2020. PMID: 32607644 Clinical Trial.

2

Does thrombolysis benefit patients with lacunar syndrome?

Cocho D, Belvís R, Martí-Fàbregas J, Bravo Y, Aleu A, Pagonabarraga J, Molina-Porcel L, Díaz-Manera J, San Roman L, Martínez-Lage M, Martínez A, Moreno M, Martí-Vilalta JL. Cocho D, et al. Among authors: pagonabarraga j. Eur Neurol. 2006;55(2):70-3. doi: 10.1159/000091982. Epub 2006 Mar 10. Eur Neurol. 2006. PMID: 16534209

3

Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.

Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, García-Sánchez C. Kulisevsky J, et al. Among authors: pagonabarraga j. Mov Disord. 2007 Jan;22(1):62-7. doi: 10.1002/mds.21205. Mov Disord. 2007. PMID: 17115388 Clinical Trial.

4

Controlled study of decision-making and cognitive impairment in Parkinson's disease.

Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Pagonabarraga J, et al. Mov Disord. 2007 Jul 30;22(10):1430-1435. doi: 10.1002/mds.21457. Mov Disord. 2007. PMID: 17534944

5

A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia.

Pagonabarraga J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A, Kulisevsky J. Pagonabarraga J, et al. Mov Disord. 2008 Feb 15;23(3):443-8. doi: 10.1002/mds.21864. Mov Disord. 2008. PMID: 18076112

6

Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening.

Clarimón J, Pagonabarraga J, Paisán-Ruíz C, Campolongo A, Pascual-Sedano B, Martí-Massó JF, Singleton AB, Kulisevsky J. Clarimón J, et al. Among authors: pagonabarraga j. Mov Disord. 2008 Mar 15;23(4):518-23. doi: 10.1002/mds.21771. Mov Disord. 2008. PMID: 18098275

7

Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck.

Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Pascual-Sedano B, Gironell A, Kulisevsky J. Aguirregomozcorta M, et al. Among authors: pagonabarraga j. Parkinsonism Relat Disord. 2008;14(5):443-5. doi: 10.1016/j.parkreldis.2007.10.007. Epub 2008 Mar 11. Parkinsonism Relat Disord. 2008. PMID: 18337152

8

Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A. Pagonabarraga J, et al. Mov Disord. 2008 May 15;23(7):998-1005. doi: 10.1002/mds.22007. Mov Disord. 2008. PMID: 18381647

9

Clopidogrel in secondary ischemic stroke prevention.

Belvís R, Pagonabarraga J, Santamaría A, Kulisevsky J. Belvís R, et al. Among authors: pagonabarraga j. Recent Pat Cardiovasc Drug Discov. 2008 Jun;3(2):119-25. doi: 10.2174/157489008784705340. Recent Pat Cardiovasc Drug Discov. 2008. PMID: 18537762 Review.

10

Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.

Llebaria G, Pagonabarraga J, Kulisevsky J, García-Sánchez C, Pascual-Sedano B, Gironell A, Martínez-Corral M. Llebaria G, et al. Among authors: pagonabarraga j. Mov Disord. 2008 Aug 15;23(11):1546-50. doi: 10.1002/mds.22173. Mov Disord. 2008. PMID: 18546326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page